A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer-Reference-Cited by-同舟云学术

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer

Published:2021-09 Issue:5 Volume:16 Page:569-589
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Moore Kathleen N.^ORCID,Hong David S.,Patel Manish R.,Pant Shubham,Ulahannan Susanna V.,Jones Suzanne,Meric-Bernstam Funda,Wang Judy S.,Aljumaily Raid,Hamilton Erika P.,Wittchen Erika S.,Wang Xuejing,Lin Aimee Bence,Bendell Johanna C.

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11523-021-00835-0.pdf

Reference44 articles.

1. McNeely S, Beckmann R, Bence Lin AK. CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy. Pharmacol Ther. 2014;142(1):1–10. https://doi.org/10.1016/j.pharmthera.2013.10.005.

2. Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer. 2008;98(3):523–8. https://doi.org/10.1038/sj.bjc.6604208.

3. King C, Diaz HB, McNeely S, Barnard D, Dempsey J, Blosser W, et al. LY2606368 causes replication catastrophe and antitumor effects through CHK1-dependent mechanisms. Mol Cancer Ther. 2015;14(9):2004–13. https://doi.org/10.1158/1535-7163.mct-14-1037.

4. Wu W, King C, Donoho G, Iversen P, Capen A, Castanares M, et al. Anti-tumor activity of the Chk1 inhibitor prexasertib (LY2606368) as a single agent in triple negative breast cancer models. Cancer Res. 2018;78(13 Suppl):336. https://doi.org/10.1158/1538-7445.am2018-336.

5. Wu W, Bi C, Bence AK, Um SL, Yan B, Starling JJ, et al. Abstract 1776: antitumor activity of Chk1 inhibitor LY2606368 as a single agent in SW1990 human pancreas orthotopic tumor model. Cancer Res. 2012;72(8 Suppl):1776. https://doi.org/10.1158/1538-7445.am2012-1776.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer;International Journal of Molecular Sciences;2024-06-05

2. Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background;International Journal of Molecular Sciences;2024-03-06

3. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

4. Update on Emerging Therapies for Advanced Colorectal Cancer;American Society of Clinical Oncology Educational Book;2023-05

5. Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?;Journal of Clinical Medicine;2023-04-20